share_log

奥翔药业2023年度独立董事述职报告(骆铭民)

Aoxiang Pharmaceutical's 2023 Independent Director Debriefing Report (Luo Mingmin)

Sensex a share ·  Apr 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more